Children are not small adults: some differences between pediatric and adult cardiac transplantation

Maryanne R Kichuk-Chrisant1

  • 1Pediatric Heart Failure and Heart Transplant Services, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk M41, Cleveland, OH 44195, USA. kichukm@ccf.org

Insights

Pediatric cardiac transplantation offers excellent survival rates for children with end-stage heart disease. Key considerations include unique indications, specialized evaluations, and comprehensive post-transplant psychosocial support for young recipients and their families.

Area of Science:

  • Cardiology
  • Pediatric Surgery
  • Transplantation Medicine

Background:

  • Cardiac transplantation is a critical treatment for end-stage heart disease in adults and children.
  • Pediatric heart transplant survival rates are comparable to adult recipients, exceeding 65% at 5 years.
  • Significant distinctions exist in pediatric cardiac transplantation concerning indications, patient evaluation, surgical approaches, and long-term management.

Purpose of the Study:

  • To highlight the viability and outcomes of cardiac transplantation in pediatric patients.
  • To outline the specific indications for heart transplantation in children.
  • To emphasize the unique challenges and considerations in pediatric cardiac transplant management.

Main Methods:

  • Review of indications for pediatric cardiac transplantation, including metabolic, genetic cardiomyopathies, and congenital heart disease.
  • Emphasis on specialized evaluation protocols for pediatric candidates, including metabolic and genetic assessments.
  • Discussion of post-transplant management focusing on pediatric-specific psychosocial needs.

Main Results:

  • Pediatric cardiac transplantation demonstrates excellent survival rates, comparable to adults.
  • Indications in children often involve complex conditions like metabolic disorders and congenital heart defects.
  • Pre-existing palliative surgeries in children with congenital heart disease can elevate surgical risks.

Conclusions:

  • Cardiac transplantation is a successful therapy for pediatric end-stage heart disease.
  • Tailored evaluation and management strategies are essential for pediatric heart transplant success.
  • Addressing psychosocial aspects is crucial for the holistic well-being of pediatric transplant recipients and their families.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...